Center Laboratories Valuation
| 4123 Stock | TWD 50.60 0.50 1.00% |
At this time, the firm appears to be overvalued. Center Laboratories shows a prevailing Real Value of NT$40.96 per share. The current price of the firm is NT$50.6. Our model approximates the value of Center Laboratories from analyzing the firm fundamentals such as Current Valuation of 27.79 B, return on equity of -0.0938, and Profit Margin of (0.96) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Center Laboratories' price fluctuation is very steady at this time. Calculation of the real value of Center Laboratories is based on 3 months time horizon. Increasing Center Laboratories' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Center stock is determined by what a typical buyer is willing to pay for full or partial control of Center Laboratories. Since Center Laboratories is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Center Stock. However, Center Laboratories' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 50.6 | Real 40.96 | Hype 50.6 | Naive 51.15 |
The intrinsic value of Center Laboratories' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Center Laboratories' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Center Laboratories helps investors to forecast how Center stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Center Laboratories more accurately as focusing exclusively on Center Laboratories' fundamentals will not take into account other important factors: Center Laboratories Total Value Analysis
Center Laboratories is presently anticipated to have takeover price of 27.79 B with market capitalization of 28.67 B, debt of 3.68 B, and cash on hands of 3.61 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Center Laboratories fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
27.79 B | 28.67 B | 3.68 B | 3.61 B |
Center Laboratories Investor Information
About 24.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.48. In the past many companies with similar price-to-book ratios have beat the market. Center Laboratories last dividend was issued on the 8th of September 2022. The entity had 1000000:1101602 split on the 5th of September 2023. Based on the key indicators related to Center Laboratories' liquidity, profitability, solvency, and operating efficiency, Center Laboratories is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Center Laboratories Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Center indicates not a very effective usage of assets in November.Center Laboratories Ownership Allocation
Center Laboratories holds a total of 594.76 Million outstanding shares. Center Laboratories retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Center Laboratories Profitability Analysis
The company reported the revenue of 500.11 M. Net Income was 1.82 B with profit before overhead, payroll, taxes, and interest of 259.66 M.About Center Laboratories Valuation
Our relative valuation model uses a comparative analysis of Center Laboratories. We calculate exposure to Center Laboratories's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Center Laboratories's related companies.Center Laboratories, Inc. engages in the manufacture and trading of various medicines in Taiwan. The company was founded in 1959 and is headquartered in Taipei, Taiwan. CENTER LABORATORIES operates under Drug ManufacturersSpecialty Generic classification in Taiwan and is traded on Taiwan OTC Exchange.
8 Steps to conduct Center Laboratories' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Center Laboratories' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Center Laboratories' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Center Laboratories' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Center Laboratories' revenue streams: Identify Center Laboratories' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Center Laboratories' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Center Laboratories' growth potential: Evaluate Center Laboratories' management, business model, and growth potential.
- Determine Center Laboratories' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Center Laboratories' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Center Stock Analysis
When running Center Laboratories' price analysis, check to measure Center Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Center Laboratories is operating at the current time. Most of Center Laboratories' value examination focuses on studying past and present price action to predict the probability of Center Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Center Laboratories' price. Additionally, you may evaluate how the addition of Center Laboratories to your portfolios can decrease your overall portfolio volatility.